ORIC Pharmaceuticals, Inc.ORICNASDAQ

Revenue (LTM)

Net Income (LTM)

$-129M

-1.3% YoY

Free Cash Flow

$-114M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0	0
Gross Profit	0	0	-1	-1↓7.3%	-1↓10.2%
Operating Income	-79	-92↓16.4%	-111↓20.7%	-143↓29.0%	-143↓0.1%
Net Income	-79	-89↓13.2%	-101↓13.0%	-128↓27.0%	-129↓1.3%
EBITDA	-78	-86↓10.0%	-110↓27.9%	-127↓15.5%	-128↓1.2%
EPS Diluted	-2.07	-2.25↓8.7%	-1.96↑12.9%	-1.83↑6.6%	-1.47↑19.7%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	226	67↓70.4%	23↓65.0%	59↑154.0%	46↓23.1%
Total Current Assets	241	210↓12.5%	213↑1.0%	262↑23.4%	288↑10.0%
Total Assets	299	250↓16.2%	255↑1.7%	274↑7.6%	411↑49.9%
Total Current Liabilities	15	15↑1.6%	20↑32.9%	25↑21.4%	20↓17.8%
Total Liabilities	26	28↑9.1%	31↑9.2%	31↑1.4%	27↓14.1%
Total Equity	273	222↓18.5%	224↑0.8%	243↑8.5%	384↑58.1%
Total Debt	2	12↑528.1%	10↓15.6%	3↓68.8%	12↑262.9%
Net Debt	-224	-55↑75.6%	-13↑75.9%	-56↓326.9%	-34↑39.3%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-60	-75↓26.2%	-86↓14.0%	-113↓31.5%	-113↓0.6%
Capital Expenditure	-1	-2↓121.3%	-1↑59.1%	-1↓39.9%	-1↑40.1%
Free Cash Flow	-60	-77↓27.7%	-87↓12.1%	-114↓31.6%	-114↓0.2%
Stock-Based Comp	13	14↑12.5%	15↑5.3%	20↑32.8%	0
Net Change in Cash	148	-159↓207.5%	-43↑72.7%	36↑182.9%	-14↓138.1%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance